CLOs on the Move


 
KCR is a clinical development solutions provider for the biotechnology, pharmaceutical, and medical device industries. We support clients with full-service clinical development capabilities across three main areas: Trial Execution, Consulting and Placement. KCR operates across four main regions: North America, Western Europe, Central Europe, and Eastern Europe, with a main operational hub located in Boston, MA. Our strategic hub locations, technical capabilities and solution offerings allow for the optimized delivery of trial execution strategies to develop life-changing therapies. KCR offers access to an estimated population of 1.1 Billion people.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.kcrcro.com
  • 30 Rowes Wharf Suite 430
    Boston, MA USA 10117
  • Phone: +48 22 313 13 13

Executives

Name Title Contact Details

Similar Companies

Canarx Services

Canarx Services is a Windsor, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ocusoft

Ocusoft is a Rosenberg, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Citizens Rx

Citizens Rx provides pharmacy benefit management services to public and private companies and offers health plans in the United States.

ANI Pharmaceuticals

ANI Pharmaceuticals is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals. We focus on niche and high barrier to entry opportunities including controlled substances, anti-cancer (oncolytics), hormones and steroids, and complex formulations. Our two pharmaceutical manufacturing facilities located in Baudette, Minnesota are capable of producing oral solid dose products, as well as liquids and topicals, controlled substances, and potent products that must be manufactured in a fully-contained environment. Our objective is to create long term shareholder value by building a sustainable and growing base business in generic and mature brand pharmaceutical products while advancing an opportunity to re-commercialize Cortrophin gel and Cortrophin-Zinc.